{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:37:26Z","timestamp":1792143446385,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.antiviral.2015.04.003","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T11:42:12Z","timestamp":1428752532000},"page":"139-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry"],"prefix":"10.1016","volume":"118","author":[{"given":"Wen-Chan","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Pang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie-Chwen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Tzung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.04.003_b0005","first-page":"211","article-title":"Isolation and identification of substances with anti-hepatitis c virus activities from Kalanchoe pinnata","volume":"6","author":"Aoki","year":"2014","journal-title":"Int. J. Pharm. Pharm. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.antiviral.2015.04.003_b0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1478-3231.2011.02699.x","article-title":"Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow","volume":"32","author":"Asselah","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.antiviral.2015.04.003_b0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2012.10.009","article-title":"Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period","volume":"58","author":"Barcena","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.04.003_b0020","series-title":"The Illustrated Medicinal Plants of Taiwan","author":"Chiu","year":"1992"},{"key":"10.1016\/j.antiviral.2015.04.003_b0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1472-765X.2010.02805.x","article-title":"In vitro anti-enterovirus 71 activity of gallic acid from Woodfordia fruticosa flowers","volume":"50","author":"Choi","year":"2010","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.antiviral.2015.04.003_b0030","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/hep.24610","article-title":"The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry","volume":"54","author":"Ciesek","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.04.003_b0035","doi-asserted-by":"crossref","first-page":"g3308","DOI":"10.1136\/bmj.g3308","article-title":"Antiviral treatment of hepatitis C","volume":"348","author":"Feeney","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.antiviral.2015.04.003_b0040","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/gutjnl-2013-304623","article-title":"In vitro infection of primary human hepatocytes by HCV-positive sera: insights on a highly relevant model","volume":"63","author":"Gondeau","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2015.04.003_b0045","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMe1401508","article-title":"Therapy for hepatitis C \u2013 the costs of success","volume":"370","author":"Hoofnagle","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2015.04.003_b0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1590\/S0074-02762008000500005","article-title":"Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate","volume":"103","author":"Kratz","year":"2008","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.antiviral.2015.04.003_b0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.antiviral.2015.04.003_b0060","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-2000-8547","article-title":"Flavonoids and phenolics from Limonium sinense","volume":"66","author":"Lin","year":"2000","journal-title":"Planta Med."},{"key":"10.1016\/j.antiviral.2015.04.003_b0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-2000-8540","article-title":"Anti-herpes simplex virus type-1 flavonoids and a new flavanone from the root of Limonium sinense","volume":"66","author":"Lin","year":"2000","journal-title":"Planta Med."},{"key":"10.1016\/j.antiviral.2015.04.003_b0070","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1128\/JVI.01492-10","article-title":"Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread","volume":"85","author":"Lin","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.04.003_b0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2180-13-187","article-title":"Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry","volume":"13","author":"Lin","year":"2013","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.antiviral.2015.04.003_b0080","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jhep.2014.10.040","article-title":"Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry","volume":"62","author":"Lin","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.04.003_b0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/2225-4110.124335","article-title":"Antiviral natural products and herbal medicines","volume":"4","author":"Lin","year":"2014","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.antiviral.2015.04.003_b0090","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.04.003_b0095","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrmicro3098","article-title":"The ins and outs of hepatitis C virus entry and assembly","volume":"11","author":"Lindenbach","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2015.04.003_b0100","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2015.04.003_b0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2012.09.034","article-title":"Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period","volume":"58","author":"Marino","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2015.04.003_b0110","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/hep.22550","article-title":"Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells","volume":"48","author":"Marukian","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.04.003_b0115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-158-5-201303050-00005","article-title":"Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"158","author":"Morgan","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.antiviral.2015.04.003_b0120","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1073\/pnas.0914009107","article-title":"Identification of hepatoprotective flavonolignans from silymarin","volume":"107","author":"Polyak","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.04.003_b0125","doi-asserted-by":"crossref","first-page":"08","DOI":"10.21065\/19204159.6.8","article-title":"In-vitro antiviral activity of Pistacia chinensis flavonoids against hepatitis c virus (HCV)","volume":"6","author":"Rashed","year":"2014","journal-title":"J. Appl. Pharm."},{"key":"10.1016\/j.antiviral.2015.04.003_b0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.virusres.2011.03.014","article-title":"Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source","volume":"158","author":"Ravikumar","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2015.04.003_b0135","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1038\/srep05411","article-title":"Small molecule inhibitors of HCV replication from pomegranate","volume":"4","author":"Reddy","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2015.04.003_b0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"Sulkowski","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2015.04.003_b0145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cld.2008.03.010","article-title":"Hepatitis C and liver transplantation: enhancing outcomes and should patients be retransplanted","volume":"12","author":"Verna","year":"2008","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.antiviral.2015.04.003_b0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1099\/vir.0.006700-0","article-title":"CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells","volume":"90","author":"Witteveldt","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.04.003_b0155","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2010.10.014","article-title":"Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies","volume":"54","author":"Zeisel","year":"2011","journal-title":"J. Hepatol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215000832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215000832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T22:45:27Z","timestamp":1651704327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215000832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":31,"alternative-id":["S0166354215000832"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.04.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}